The effectiveness of oral midazolam as a hypnotic compared with lorazepam

A double-blind closed sequential scheme study was carried out in 82 patients with insomnia to compare the hypnotic effectiveness of 15 mg midazolam and 1 mg lorazepam. Pairs of randomized patients were treated on one and the same night with midazolam or lorazepam, respectively. Eight parameters were...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1986), 7 vom: 01., Seite 463-71
1. Verfasser: Lorizio, A (VerfasserIn)
Weitere Verfasser: Salsa, F
Format: Aufsatz
Sprache:English
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Benzodiazepines 12794-10-4 Lorazepam O26FZP769L Midazolam R60L0SM5BC
LEADER 01000naa a22002652 4500
001 NLM029195292
003 DE-627
005 20231221111421.0
007 tu
008 231221s1986 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0098.xml 
035 |a (DE-627)NLM029195292 
035 |a (NLM)2938195 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Lorizio, A  |e verfasserin  |4 aut 
245 1 4 |a The effectiveness of oral midazolam as a hypnotic compared with lorazepam 
264 1 |c 1986 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 25.04.1986 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a A double-blind closed sequential scheme study was carried out in 82 patients with insomnia to compare the hypnotic effectiveness of 15 mg midazolam and 1 mg lorazepam. Pairs of randomized patients were treated on one and the same night with midazolam or lorazepam, respectively. Eight parameters were recorded for each member of the pair. The time taken to fall asleep, the duration of sleep and the overall assessment of response showed that midazolam was significantly superior to lorazepam: the number of awakenings and evaluation by the patient verged on statistical significance. Both drugs were equal for the quality of sleep, dreams and the patient's condition on awakening. No side-effects were observed in any of the patients 
650 4 |a Clinical Trial 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Randomized Controlled Trial 
650 7 |a Benzodiazepines  |2 NLM 
650 7 |a 12794-10-4  |2 NLM 
650 7 |a Lorazepam  |2 NLM 
650 7 |a O26FZP769L  |2 NLM 
650 7 |a Midazolam  |2 NLM 
650 7 |a R60L0SM5BC  |2 NLM 
700 1 |a Salsa, F  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 4(1986), 7 vom: 01., Seite 463-71  |w (DE-627)NLM023961570 
773 1 8 |g volume:4  |g year:1986  |g number:7  |g day:01  |g pages:463-71 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 4  |j 1986  |e 7  |b 01  |h 463-71